Search results
Prescription transfer bills cross finish line at General Assembly
Rhode Island Current via Yahoo News· 6 days agoWant to transfer your Adderall prescription from one pharmacy to another? Legislation passed by the...
Opioids Lawyers Offer Investors Piece of $100 Million-Plus Win
Bloomberg Law· 1 day agoA law firm set to earn more than $100 million for its work on opioids cases is packaging its fees and selling it to investors as a security. Napoli Shkolnik PLLC is pooling its portion of approximately ...
Deckers X Lab unveils Enduro Lite Low carbon-plated hiking shoes for adventurous hikers
T3 via Yahoo News· 2 days agoThe Enduro Lite Low, brought to you by Deckers X Lab, the innovative minds behind HOKA ONE ONE, Teva...
AbbVie (ABBV) Buys Global Rights to Novel IBD Candidate
Zacks· 4 days agoAbbVie (ABBV) signs an exclusive global licensing deal with the Chinese company FutureGen to develop FG-M701, a next-generation TL1A antibody, for IBD indications.
Wellington Management Group LLP Trims Position in Deckers Outdoor Co. (NYSE:DECK)
ETF DAILY NEWS· 10 hours agoWellington Management Group LLP lessened its stake in shares of Deckers Outdoor Co. (NYSE:DECK – Free Report) by 13.0% in the fourth quarter, according to its most recent filing with the Securities ...
This Biopharma Stock Could More Than Double
TheStreet.com· 5 days agoThe stock recently gapped higher and keeps on going. In the daily bar chart of INSM, below, I can see that share prices gapped sharply higher in late...
Growth management, opioid plans head to Carson supervisors
Nevada Appeal· 14 hours agoBefore evaluating how best to combat opioid use in the community, the Carson City Board of Supervisors will review a resolution Thursday to set the maximum number of residential building permits ...
Alvotech and STADA to co-develop biosimilars for bone disease treatments
BioPharma-Reporter· 5 days agoDenosumab is designed to block a protein called RANKL, stopping bone cells called osteoclasts from...
AbbVie joins TL1A race via $150M upfront deal with China's FutureGen
FierceBiotech· 5 days agoAbbVie has become the latest Big Pharma to jump on the anti-TL1A train, paying China’s FutureGen Biopharmaceutical $150 million upfront for a preclinical inflammatory bowel disease (IBD) candidate ...
EP Wealth Advisors LLC Increases Stock Holdings in Deckers Outdoor Co. (NYSE:DECK)
ETF DAILY NEWS· 1 day agoEP Wealth Advisors LLC boosted its position in Deckers Outdoor Co. (NYSE:DECK – Free Report) by 10.1% during the 4th quarter, according to its most recent Form 13F filing with the SEC. EP Wealth ...
